Insider buying last 90 days
No open-market insider purchases were filed for TFX in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every TFX insider filing, plotted on the chart in Gekko.Open TFX in Gekko
NYSE: TFX
Teleflex (TFX) Stock Analysis & Forecast
Sep 28 close
$127.38+5.31 (+4.3%)
Gekko Brief
AI summaryTeleflex draws attention this week after a research upgrade to "Strong-Buy" following quarterly results that beat consensus, with EPS of $1.76 and revenue up 28.9% year-over-year to $570.33 million. Coverage remains mixed elsewhere: Argus lowered its target price to $131.00, while another analysis pointed to a potential 23.31% upside tied to the same revenue growth. Broader market weakness also weighed on the stock during a session that mirrored a slight decline in the S&P 500.
Shares close at $127.38, up 4.3%, sitting between the 50-day average of $133.78 and the 200-day average of $124.09, reflecting a mixed trend. The GekkoIndex reads 63.9, placing Teleflex in the Accumulation zone. Price sits about 1% below Gekko Fair Value of $128.63, keeping the gap narrow.
The next earnings report is set for 5 November 2026, before the open, 37 days away and outside a typical 20-trading-day holding window. Smart-money indicators show one billionaire holder and no trailblazer holders, with no insider, Congress, or options activity recorded in their respective windows. Seasonality over the past 5 years shows the next 20 trading days averaging -1.1%, rising in 2 of those years. Analyst coverage from 9 firms shows 6 buy and 3 hold ratings, with a consensus target of $153.55 and consensus upside of 20.5%.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Teleflex price vs fair value
Close $127.38200-day averageGekko Fair Value $128.63
Teleflex quick facts
- Market cap
- $5.64B
- P/E ratio
- —
- Forward P/E
- 11
- EPS, TTM
- −$0.53
- Revenue, TTM
- $2.25B
- Profit margin
- -45.8%
- Dividend yield
- 1.12%
- Beta
- 0.81
- Volume
- 1.56M avg 816,276
- 1-year return
- +8.9%
- Typical daily move
- ±3.1%
- Typical 20-day move
- ±5.7%
- 50-day average
- $133.78
- 200-day average
- $124.09
- Next earnings
- Nov 5 before open
- Shares outstanding
- 42.37M
Teleflex swing-trade checklist
Teleflex scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $127.38 sits between the 50-day ($133.78) and 200-day ($124.09) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
63.9, Accumulation
Reading 63.9 is in the Accumulation zone.
See the GekkoIndex - Fair valuemixed
1.0% below
Price is within 5% of Gekko Fair Value (1% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 37 days
Next report Nov 5, 2026, 37 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalityheadwind
−1.1% on average
From this point in the calendar, the next 20 trading days averaged −1.1% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Teleflex stock chart and price history
Teleflex closed at $127.38 on Sep 28, 2026, +8.9% over the past year, inside a 52-week range of $100.18 to $145.00.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −7.5%
- 3 months
- −0.1%
- 6 months
- +9.6%
- 1 year
- +8.9%
The full TFX chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open TFX in Gekko
Follow Teleflex through every session
Put TFX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track TFX in GekkoFree for 7 days. No credit card required.
About Teleflex
Teleflex designs and produces disposable medical devices that clinicians rely on for both diagnosis and treatment, mainly in surgical and critical care settings. It has built recognition around its Arrow-branded vascular access tools, such as catheters and systems for guiding and positioning catheter tips, as well as the UroLift System, which addresses urinary symptoms tied to enlarged prostate conditions.
The business spans multiple product areas, including vascular access, interventional cardiology and radiology, anesthesia and surgical equipment, urology, and respiratory care. Offerings under these areas include coronary and structural heart devices, tools for peripheral vascular and cardiac procedures, pain management and surgical instruments, catheterization and endourology equipment, plus devices for oxygen delivery and breathing support. Buyers of these products include hospitals, clinicians, emergency responders, military medical units, other device makers, and providers of home healthcare.
Teleflex traces its founding to 1943 and runs its operations from Wayne, Pennsylvania. Its stock trades on the NYSE under the symbol TFX.
- Listed
- NYSE
- Sector
- Health technology
- Industry
- Medical specialties
- Website
- teleflex.com
Teleflex GekkoIndex: the smart money zone
Teleflex’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 63.9, in the Accumulation zone, down 12.1 points over five sessions.
63.9Accumulation
Down 12.1 points over five sessions, from the Buying zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 50 | −0.5% | +0.2% | ||
| Accumulation (current zone) | 278 | +0.4% | −0.8% | ||
| Neutral | 328 | −0.9% | −2.2% | ||
| Distribution | 14 | −3.2% | −5.0% | ||
| Selling | 2 | Too few readings yet | |||
Average TFX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.3% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
See every daily GekkoIndex reading plotted over the TFX price, zone by zone.Track TFX in Gekko
Is Teleflex stock overvalued? Gekko Fair Value
Teleflex trades 1.0% below Gekko Fair Value of $128.63, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Teleflex shares are worth, recalculated every trading day.
$128.63
Gekko Fair Value, Sep 26, 2026
1.0% below fair value · About fair value
Gekko Fair Value on every chart, with the gap to price updating daily.Open TFX in Gekko
Teleflex insider and Congress trading
No open-market insider purchases were filed for Teleflex, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in TFX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for TFX, plotted on the chart in Gekko.Open TFX in Gekko
Buybacks
Teleflex has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $245.4M
- As a share of market cap
- 4.35%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds TFX.
0added0opened1trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Teleflex earnings: next date and track record
Teleflex reports on Nov 5, 2026, before the open (37 days away), and beat the EPS estimate in 6 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected before the open, 37 days away
- EPS estimate
- $1.90
- Revenue estimate
- $565.4M
6 of 8reports beat the EPS estimate
±6.7%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Apr 30, 2026 | $0.00 est $2.99 | — | −8.6% |
| Feb 19, 2026 | $1.93 est $3.79 | $569.0M est $919.3M | +2.6% |
| Nov 6, 2025 | $3.67 est $3.38 | $913.0M est $915.0M | −12.3% |
| Jul 30, 2025 | $3.73 est $3.36 | $780.9M est $892.9M | +3.5% |
| Apr 30, 2025 | $2.91 est $2.88 | $700.7M est $766.1M | −8.9% |
| Feb 20, 2025 | $3.89 est $3.88 | — | +0.5% |
| Oct 31, 2024 | $3.49 est $3.39 | $764.4M est $813.3M | −10.2% |
| Aug 1, 2024 | $3.42 est $3.33 | $749.7M est $763.0M | +7.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Teleflex stock forecast and analyst price targets
Analysts’ average 12-month price target for Teleflex is $153.55, +20.5% from the last close, from 9 firms rating the stock in the last 90 days.
$153.55consensus 12-month target, +20.5% from the last close
Now $127.38Avg $153.55
Low $145High $170
Each firm’s latest rating in the last 90 days: 9 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 28 | Bank of America Securities | $158 | +24.0% |
| Sep 18 | Piper Sandler | $169 | +32.7% |
| Aug 25 | Needham | $170 | +33.5% |
| Aug 11 | UBS | $158 | +24.0% |
| Aug 10 | Truist Financial | $150 | +17.8% |
−0.8%average 20-day move after past Accumulation readings
−1.1%average move over the next 20 trading days in the last 5 years
±3.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Teleflex seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Teleflex averaged −1.1% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.2% | 2 of 5 |
| Next 10 trading days | −4.3% | 0 of 5 |
| Next 15 trading days | −1.5% | 1 of 5 |
| Next 20 trading days | −1.1% | 2 of 5 |
| Next 30 trading days | −6.7% | 2 of 5 |
For scale, TFX’s typical 20-trading-day move in either direction is about 5.7%.
Teleflex market cap and key statistics
Teleflex’s market cap is $5.64B and revenue of $2.25B over the last twelve months.
Valuation
- Market cap
- $5.64B
- Forward P/E
- 11
- EPS, TTM
- −$0.53
- Gekko Fair Value
- $128.63
Trading
- Volume
- 1.56M
- Avg volume, 20 days
- 816,276
- 52-week high
- $145.00
- 52-week low
- $100.18
- Shares outstanding
- 42.37M
Financials
- Revenue, TTM
- $2.25B
- Profit margin
- -45.8%
- Return on equity
- -0.7%
- Quarterly earnings growth, YoY
- −17.3%
Risk and income
- Beta
- 0.81
- Typical daily move
- ±3.1%
- Typical 20-day move
- ±5.7%
- Dividend yield
- 1.12%
Teleflex stock news this week
Coverage of Teleflex this week reads positive: 3 positive, 1 neutral and 1 negative headlines.
- Zacks Research Upgrades Teleflex (NYSE:TFX) to "Strong-Buy"MarketBeat, Sep 26
- Teleflex Inc. stock heads into the open after a market-led declineAD HOC NEWS, Sep 25
- Teleflex Incorporated (TFX) Stock forecastsYahoo Finance Singapore, Sep 25
- Corient Private Wealth LP Has $2.92 Million Holdings in Teleflex Incorporated $TFXMarketBeat, Sep 22
- Teleflex Incorporated (TFX) Stock Analysis: Potential 23% Upside Amid Strong Revenue GrowthDirectorsTalk Interviews, Sep 21
Teleflex peers
Teleflex’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 23.7% above |
| ABTAbbott Laboratories | Accumulation | 15.0% below |
| DHRDanaher | Distribution | 10.2% above |
| ISRGIntuitive Surgical | Neutral | 17.0% above |
| MDTMedtronic | Accumulation | 24.1% below |
| SYKStryker | Accumulation | 14.1% below |
A peer links to its own page where one exists.
Teleflex stock FAQ
What is Teleflex’s market cap?
Teleflex’s market cap is $5.64B at the Sep 28, 2026 close of $127.38, with 42.37M shares outstanding.
What is the Teleflex stock forecast?
The consensus analyst 12-month price target for Teleflex is $153.55, +20.5% from the last close. Of the 9 firms that rated the stock in the last 90 days, 6 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Teleflex stock overvalued or undervalued?
On Gekko’s estimate Teleflex is about fair value: the Sep 28, 2026 close of $127.38 is 1.0% below Gekko Fair Value of $128.63. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Teleflex report earnings next?
Teleflex is expected to report on Nov 5, 2026, before the market opens (37 days away). Analysts expect earnings of $1.90 per share on revenue of $565.4M. Teleflex beat the earnings estimate in 6 of its last 8 reports, moving 6.7% on average across the report.
What is Teleflex’s 52-week high and low?
Teleflex’s 52-week high is $145.00 and its 52-week low is $100.18; it closed at $127.38 on Sep 28, 2026, +8.9% over the past year. Over the last five years the shares peaked at $391.10 on Sep 29, 2021.
Is Teleflex stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and earnings risk), 2 as mixed (trend and fair value) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Teleflex the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.